Presentation Information
[P3-01]Multi-laboratory study of LC/MS method development for the quantification of cyclorasin 9A5 in plasma
*Rika Ishikawa1, Kosuke Saito1, Mikio Shirasaki2, Koichi Shiga2, Koichiro Hotta3, Kiyomi Kikuchi3, Ryoma Yamamoto4, Kentaro Takahara4, Takuma Shigeyama5, Risa Hamada5, Hisashi Fujita6, Masaaki Kakehi6, Masayoshi Saito7, Yukiko Sugawara7, Yuki Kishino8, Hitomi Shimoda8, Ryoya Goda9, Yoshiro Saito1, Ruri Kikura-Hanajiri1 (1. National Institute of Health Sciences, 2. Axcelead Drug Discovery Partners, Inc., 3. Eisai Co., Ltd., 4. Thermo Fisher Scientific, 5. Sumika Chemical Analysis Service, Ltd., 6. Takeda Pharmaceutical Co., Ltd., 7. Mitsubishi Tanabe Pharma Corporation, 8. Daiichi Sankyo Co., Ltd., 9. Future Peak)
Keywords:
Cyclic peptides,Liquid chromatography/mass spectrometry,Cyclorasin 9A5
Password required to view
Log in
or